Spacer
Spacer
SEARCH
Spacer
Spacer
Quotes News NAV
Spacer
Spacer
Spacer
Spacer
Spacer
Balance Sheet Markets  >  Corporate Information  >   Balance Sheet
Spacer
Accretion Nutraveda Ltd Industry:  Pharmaceuticals - Indian - Formulations
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
544694 INE1KVQ01019 48.9961326 Not Listed 0 208.51 0 0 10
Your Result on : Markets | Equity | Corporate Information | Balance Sheet
      ParticularsMar 2026
(Rs.Cr)
Mar 2025
(Rs.Cr)
Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
SOURCES OF FUNDS :    
Share Capital 7.240.490.360.36
Reserves Total 28.234.560.72-0.10
Equity Share Warrants0.000.000.000.00
Equity Application Money0.000.000.000.00
Total Shareholders Funds35.475.051.080.26
Secured Loans 0.361.931.421.30
Unsecured Loans 3.871.930.750.67
Total Debt4.233.862.171.97
Other Liabilities0.000.000.000.00
Total Liabilities39.708.913.252.23
APPLICATION OF FUNDS :    
Gross Block 2.862.782.031.97
Less : Accumulated Depreciation 1.210.950.750.48
Less:Impairment of Assets0.000.000.000.00
Net Block 1.651.831.281.49
Lease Adjustment0.000.000.000.00
Capital Work in Progress0.000.000.100.00
Producing Properties0.000.000.000.00
Investments 0.000.000.000.00
Current Assets, Loans & Advances    
Inventories 8.994.592.381.30
Sundry Debtors 8.113.270.250.80
Cash and Bank Balance9.740.020.120.09
Loans and Advances 3.420.820.510.39
Total Current Assets30.278.703.252.57
Less : Current Liabilities and Provisions    
Current Liabilities 0.901.071.271.80
Provisions 1.180.560.100.00
Total Current Liabilities & Provisions2.081.631.371.80
Net Current Assets28.197.071.880.77
Miscellaneous Expenses not written off 0.000.000.000.00
Deferred Tax Assets0.000.010.000.00
Deferred Tax Liability0.000.000.010.02
Net Deferred Tax0.000.01-0.01-0.02
Other Assets9.860.000.000.00
Total Assets39.718.913.262.24
Contingent Liabilities0.000.000.000.00
Spacer
Spacer